Swiss stocks finished largely unchanged on Thursday. The market built up some modest gains during the morning, continuing a stabilization that has followed Monday's sharp decline. However, weak economic news out of the U.S. hampered stocks during the afternoon.
Sentiment was also dampened by lingering concerns about the European debt situation. This was exasperated by worries that the IMF will not pay the next credit tranche for Greece.
The benchmark SMI ticked up 0.07 percent on the day to close at 6,469.16. The SLI gained 0.08 percent to 1,007.78. The SPI advanced 0.07 percent to 5,947.06.
Financial stocks helped steady the market, despite the European debt concerns. UBS rose 0.6 percent on a report that the firm plans to separate its investment bank and incorporate it outside of Switzerland. Elsewhere in the sector, Credit Suisse climbed 1.0 percent, while Julius Baer advanced 1.1 percent.
Nobel Biocare was one of the best performers on the day. The stock rose 6.3 percent on positive analyst comments. Morgan Stanley raised its rating on the stock to Overweight from Underweight, citing substantive improvement in the dental implant market.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.